Digestive Remedies in Nigeria
Euromonitor International's Digestive Remedies in Nigeria market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 30 | Publication date: Nov 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Child-specific digestive remedies; Diarrhoeal remedies; IBS treatments; Indigestion and heartburn remedies; Laxatives; Motion sickness remedies
Table of contents
DIGESTIVE REMEDIES IN NIGERIA : MARKET INSIGHT
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 1 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 2 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 3 Herbal vs Standard Digestive Remedies 2003-2008
Table 4 Digestive Remedies Company Shares by Value 2004-2008
Table 5 Digestive Remedies Brand Shares by Value 2005-2008
Table 6 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 7 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - NIGERIA
EMZOR PHARMACEUTICAL INDUSTRIES LTD - OTC HEALTHCARE - NIGERIA
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Emzor Pharmaceutical Industries Ltd: Key Facts
Summary 2 Emzor Pharmaceutical Industries Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 3 Emzor Pharmaceutical Industries Ltd: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 4 Emzor Pharmaceutical Industries Ltd: Competitive Position 2008
EVANS MEDICAL PLC - OTC HEALTHCARE - NIGERIA
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Evans Medical Plc: Key Facts
Summary 6 Evans Medical Plc: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 7 Evans Medical Plc: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 8 Evans Medical Plc: Competitive Position 2008
FIDSON HEALTHCARE LTD - OTC HEALTHCARE - NIGERIA
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Fidson Healthcare Ltd: Key Facts
Summary 10 Fidson Healthcare Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 11 Fidson Healthcare Ltd: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 12 Fidson Healthcare Ltd: Competitive Position 2007
OTC HEALTHCARE IN NIGERIA
EXECUTIVE SUMMARY
Analgesics lead OTC healthcare vibrancy in 2008
The greatest threat to OTC healthcare growth is high presence of counterfeit products
Distribution of drugs remains largely unstructured
OTC healthcare market remains highly fragmented
High potential for growth
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 9 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 10 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 11 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 12 OTC Healthcare Company Shares by Value 2004-2008
Table 13 OTC Healthcare Brand Shares by Value 2005-2008
Table 14 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 15 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 16 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 17 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
Vitamins & Dietary Supplements Registration and Classification
Generics
Switches
DEFINITIONS
Summary 13 Research Sources